Mini-Review on the Glucose Metabolism Modifications after Pancreatic Resection

Article Preview

Abstract:

Pancreatic cancer is one of the most severe malignant disease, with an extreme degree of lethality, considering that the survival rate at 5 years is up to 4%. In addition, a major disadvantage of this disease is the fact that the diagnosis is determined very late in the evolution of the disorder, despite the development of new technologies. In this way, the main symptoms are occurring later on, when the tumour is already locally advanced and unresectable. Up to now surgery is the only modality that can provide a greater chance of survival, but unfortunately the pancreatic resection has many unknowns and controversies around it. Moreover, the studies on endocrine pancreatic function after resection are very few and somehow controversial. In this way, in the present mini-review we will describe the most relevant experimental data regarding the post-resection pancreatogenic diabetes, the pancreatic polypeptide PP and the pancreatic glucose metabolism after resection or the glucose metabolism after partial or total pancreatectomy.

Info:

Pages:

65-71

Citation:

Online since:

April 2016

Export:

Share:

Citation:

* - Corresponding Author

[1] V. Surlin, V. Bintintan, F. Petrariu, R. Dobrin, R. Lefter, A. Ciobică, D. Timofte, Prognostic factors in resectable pancreatic cancer, Rev Med Chir Soc Med Nat Iasi. 118 (2014) 924-31.

Google Scholar

[2] D. Timofte, R. Danila, A. Ciobica, C. Diaconu, R. Livadaru, L. Ionescu, The relevance of some tumoral markers in patients with pancreatic cancer, Analele Stiintifice ale Universitatii" Al. I. Cuza" Din Iasi. 15 (2014) 51-58.

Google Scholar

[3] C. Morrow, Chronic pancreatitis: long-term surgical results of pancreatic duct drainage, pancreatic resection, and near-total pancreatectomy and islet autotransplantation, Surgery. 96 (1984) 608-16.

Google Scholar

[4] H. Beger, M. Buchler, Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head, World J Surg. 14 (1990) 83-7.

DOI: 10.1007/bf01670550

Google Scholar

[5] L. Traverso, R.A. Kozarek, Pancreatoduodenectomy for chronic pancreatitis: anatomic selection criteria and subsequent long-term outcome analysis, Ann Surg. 226 (1997) 429-35.

DOI: 10.1097/00000658-199710000-00004

Google Scholar

[6] R. Schwarz, D. Smith, Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database, Ann Surg Oncol. 13 (2006) 1189–1200.

DOI: 10.1245/s10434-006-9016-x

Google Scholar

[7] A. Andren-Sandberg I. Ihse, Factors influencing survival after total pancreatectomy in patients with pancreatic cancer, Ann Surg. 198 (1983) 605-10.

DOI: 10.1097/00000658-198311000-00008

Google Scholar

[8] D. Krusch, T. Pruett, G. Cornett, J. Hanks, Surgical alterations of the pancreas and insulin-independent glucose disposal, J Surg Res. 52 (1992) 476-82.

DOI: 10.1016/0022-4804(92)90315-q

Google Scholar

[9] R. Nosadini, Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes. 31 (1982) 346-55.

DOI: 10.2337/diabetes.31.4.346

Google Scholar

[10] H. Karmann, F. Laurent, P. Mialhe, Pancreatic hormones disappearance after total pancreatectomy in the duck: correlation between plasma glucagon and glucose. Horm Metab Res. 19 (1987) 538-41.

DOI: 10.1055/s-2007-1011877

Google Scholar

[11] R. Unger, Glucagon physiology and pathophysiology, N Engl J Med. 285 (1971) 443-9.

Google Scholar

[12] S. Kreutzenberg, Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion, J Clin Endocrinol Metab. 70 (1990) 1023-9.

DOI: 10.1210/jcem-70-4-1023

Google Scholar

[13] L. Slezak, D. Andersen, Pancreatic resection: effects on glucose metabolism, World J Surg. 25 (2001) 452-60.

DOI: 10.1007/s002680020337

Google Scholar

[14] A. Fowden, W. Hay, The effects of pancreatectomy on the rates of glucose utilization, oxidation and production in the sheep fetus, Q J Exp Physiol. 73(1988) 973-84.

DOI: 10.1113/expphysiol.1988.sp003231

Google Scholar

[15] C. Frey C. Child, W. Fry, Pancreatectomy for chronic pancreatitis, Ann Surg. 184 (1976) 403-13.

Google Scholar

[16] N. Seymour, Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide, Am J Surg. 169 (1995) 105-9.

Google Scholar

[17] D. Andersen, C Ruiz, C Burant, Insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis, Ann Surg. 219 (1994) 679-86.

DOI: 10.1097/00000658-199406000-00011

Google Scholar

[18] A. Ciobica, V. Bild, L. Hritcu, M. Padurariu, W. Bild, Effects of angiotensin II receptor antagonists on anxiety and some oxidative stress markers in rat, Central European Journal of Medicine. 6 (2011) 331-340.

DOI: 10.2478/s11536-011-0010-8

Google Scholar

[19] W Bild, A Ciobica, Angiotensin-(1–7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala, Journal of affective disorders. 145 (2013) 165-171.

DOI: 10.1016/j.jad.2012.07.024

Google Scholar

[20] W. Bild, L. Hritcu, C. Stefanescu, A. Ciobica, Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus, Progress in Neuro-Psychopharmacology and Biological Psychiatry. 43 (2013) 79-88.

DOI: 10.1016/j.pnpbp.2012.12.009

Google Scholar

[21] N. Seymour, Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man, Surgery. 104 (1988) 119-29.

Google Scholar

[22] M. Buchler, Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis, Am J Surg. 169 (1995) 65-9.

DOI: 10.1016/s0002-9610(99)80111-1

Google Scholar

[23] G. Aspelund, Improved outcomes for benign disease with limited pancreatic head resection, J Gastrointest Surg. 9 (2005) 400-9.

Google Scholar

[24] H. Ho, C Frey, The Frey procedure: local resection of pancreatic head combined with lateral pancreaticojejunostomy, Arch Surg. 136 (2001) 1353-8.

DOI: 10.1001/archsurg.136.12.1353

Google Scholar

[25] H. Dammann, Gut-hormone profile in totally pancreatectomised patients, Gut. 22(1981) 103-7.

DOI: 10.1136/gut.22.2.103

Google Scholar

[26] G. Boden, Glucagon deficiency and hyperaminoacidemia after total pancreatectomy, J Clin Invest. 65 (1980) 706-16.

DOI: 10.1172/jci109717

Google Scholar